Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) FCF Margin (2016 - 2025)

Historic FCF Margin for Nutex Health (NUTX) over the last 17 years, with Q3 2025 value amounting to 37.05%.

  • Nutex Health's FCF Margin rose 292100.0% to 37.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.97%, marking a year-over-year increase of 110300.0%. This contributed to the annual value of 4.34% for FY2024, which is 76700.0% up from last year.
  • Nutex Health's FCF Margin amounted to 37.05% in Q3 2025, which was up 292100.0% from 10.86% recorded in Q2 2025.
  • Nutex Health's 5-year FCF Margin high stood at 129.92% for Q2 2021, and its period low was 46.46% during Q3 2022.
  • Over the past 5 years, Nutex Health's median FCF Margin value was 10.86% (recorded in 2025), while the average stood at 15.13%.
  • In the last 5 years, Nutex Health's FCF Margin surged by 2607300bps in 2021 and then tumbled by -1133200bps in 2022.
  • Nutex Health's FCF Margin (Quarter) stood at 54.74% in 2021, then plummeted by -58bps to 23.05% in 2022, then tumbled by -106bps to 1.36% in 2023, then soared by 90bps to 0.13% in 2024, then surged by 28163bps to 37.05% in 2025.
  • Its FCF Margin was 37.05% in Q3 2025, compared to 10.86% in Q2 2025 and 24.03% in Q1 2025.